# POSITRON     CORPORATION (POSC) · Edgar & Edgarette company card

> Positron (POSC) saw revenue fall 21.5% in FY2025 to $0 million, operating margin -2275% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 36.1% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 844985 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/POSC) · [JSON](https://www.pops4.com/boards/company/POSC.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $461,452 |
| Revenue growth, 1 year | -21.5% |
| Revenue growth per year | -13.0% |
| Operating margin | -2275.1% (prior year -375.3%) |
| Net margin | -2297.8% |
| Operating cash flow | −$5M |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | $153,686 |
| Total assets | $4M |
| Total equity | $1M |
| Equity ÷ assets | 36.1% |
| Return on equity | -734.4% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -133.64 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed auditor change in the last 12 months; operating cash flow was negative (-$4.7M in FY2025); operating loss: a margin of -2275.1% in FY2025; revenue is hard to predict: its 80% range is ±53%

## Edgarette's reading

Exposure: revenue $461K (FY2025), total debt $154K. Experience: revenue down 21.5% on the year, down 13.0% a year over 13 years; operating margin -2275.1%, down from -375.3%. Soundness: equity 36.1% of assets, return on equity -734.4%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $182K and $587K next year (method v4.1: its own 1-year record of growth weighed at 0% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $168K to $638K. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, electromedical & electrotherapeutic apparatus): operating margin -2275.1% against a 7.5% median; growth -21.5% against 8.3%.

Range logged 2026-10-05, receipt 78d2f9bda36611f3, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 4.01 Auditor change: 1, latest 2025-12-16 ([filing](https://www.sec.gov/Archives/edgar/data/844985/000153949725003303/0001539497-25-003303-index.htm))

## Recent filings

- 10-Q · filed 2026-11-13 · [filing](https://www.sec.gov/Archives/edgar/data/844985/000153949726002979/0001539497-26-002979-index.htm)
- 8-K · filed 2026-10-02 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/844985/000153949726002637/0001539497-26-002637-index.htm)
- 8-K · filed 2026-08-18 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/844985/000153949726002298/0001539497-26-002298-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/844985/000153949726002265/0001539497-26-002265-index.htm)
- 10-Q · filed 2026-05-15 · [filing](https://www.sec.gov/Archives/edgar/data/844985/000153949726001456/0001539497-26-001456-index.htm)
- 10-K · filed 2026-03-31 · [filing](https://www.sec.gov/Archives/edgar/data/844985/000153949726001063/0001539497-26-001063-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000844985.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=844985

## Cite

POPS4, Edgar & Edgarette: POSITRON     CORPORATION (POSC) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/POSC. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

